Francis M. Cuss

Francis M. Cuss is a declared insider at 2 companies; the most frequent names are Bristol Myers Squibb Co and Rubius Therapeutics, Inc. Over a trading history stretching from 1 March 2011 to 20 July 2018, the count stands at 120 filings.

On the open market, the record shows 1 purchase worth €197k and 5 sales worth €16.3M. Taken together, the sales exceed the purchases by €16.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 43 share grants and 49 option exercises. Since January 2018: 1 purchase and no sales on the market.

On 23 July 2018 came the latest disclosure, an open-market purchase for €197k in Rubius Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.